Objective
To evaluate the safety and efficacy of simplified regional citrate anticoagulation in sustained low efficiency dialysis (SLED).
Methods
We prospectively analyzed the patients with acute kidney injury or end stage renal disease in Department of Nephrology, West China Hospital of Sichuan University from March 2017 to May 2018. All the patients received SLED treatment by Fresenius 4008s ARrTplus through either femoral or internal jugular venous catheter, with each session of SLED treatment lasting for 8 to 10 hours. We pumped in 4% tri-sodium citrate solution through the arterial line at 300 mL/h and citrate infusion was stopped 15 minutes before ending of treatment. The blood flow was 150 mL/min while the calcium-containing dialysate (Ca 1.25 mmol/L) was delivered at 200 mL/min. We recorded peripheral, post filter ionized calcium level, and systemic citrate concentration at 0, 2 and 6 hours, respectively.
Results
Sixty-two patients underwent 185 sessions of SLED. Three sessions of two patients were discontinued for filter clotting, while the rest 182 SLED sessions (98.4%) were all successfully completed. The systemic citrate concentrations at 2 and 6 hours after beginning were of no statistical difference [(0.82±0.31) vs. (0.86±0.31) mmol/L, P=0.21]. The 0-, 2-, 6-hour peripheral blood ionized calcium levels were (1.12±0.21), (1.09±0.12), and (1.11±0.09) mmol/L, respectively, with no significant difference (P>0.05), and post filter ionized calcium at 2 and 6 hours after beginning were recorded as (0.35±0.06) and (0.31±0.04) mmol/L. The trans-membrane pressure at 2 and 6 hours after beginning were (106.2±13.8) and (105.3±22.4) mm Hg (1 mm Hg=0.133 kPa), with no significant difference (P=0.42). At 6 hours after beginning, prothrombin time and activated partial thrombin time were identified to be similar to those before SLED. During SLED treatments, in 4 sessions (2.2%), patients suffered mild metabolic alkalosis, but all of them recovered 4 hours later by themselves. No bleeding complication, thrombocytopenia, cardiac arrhythmia, hypernatremia, metabolic alkalosis or hypotension was observed.
Conclusion
SLED under simplified citrate anticoagulation is safe and effective by using calcium containing dialysate, which achieves satisfying regional anticoagulation effect without interfering systemic clotting function, and provides a new option of anticoagulation for SLED.
Citation:
ZHANG Ling, LI Peiyun, WEI Tiantian, YANG Yingying, CHEN Zhiwen, LIN Li, FU Ping. Simplified regional citrate anticoagulation in sustained low efficiency dialysis. West China Medical Journal, 2018, 33(7): 838-842. doi: 10.7507/1002-0179.201807011
Copy
Copyright © the editorial department of West China Medical Journal of West China Medical Publisher. All rights reserved
1. |
付平, 张凌. 杂合肾脏替代治疗的临床应用. 中国血液净化, 2011, 10(1): 7-9.
|
2. |
Zhang L, Yang J, Eastwood GM, et al. Extended daily dialysis versus continuous renal replacement therapy for acute kidney injury: a meta-analysis. Am J Kidney Dis, 2015, 66(2): 322-330.
|
3. |
王婷立, 张凌, 陈志文, 等. 枸橼酸抗凝在持续缓慢低效血液透析中的应用. 中华内科杂志, 2014, 53(12): 953-956.
|
4. |
张凌, 王婷立, 赵宇亮, 等. 枸橼酸抗凝在持续缓慢低效血液透析中的疗效及安全性. 中华内科杂志, 2013, 52(6): 459-463.
|
5. |
Zhang L, Liao Y, Xiang J, et al. Simplified regional citrate anticoagulation using a calcium-containing replacement solution for continuous venovenous hemofiltration. J Artif Organs, 2013, 16(2): 185-192.
|
6. |
Mishra SB, Azim A, Prasad N, et al. A pilot randomized controlled trial of comparison between extended daily hemodialysis and continuous veno-venous hemodialysis in patients of acute kidney injury with septic shock. Indian J Crit Care Med, 2017, 21(5): 262-267.
|
7. |
Kitchlu A, Adhikari N, Burns KE, et al. Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study. BMC Nephrol, 2015, 16: 127.
|
8. |
Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract, 2012, 120(4): C179-C184.
|
9. |
Chawla LS, Bellomo R, Bihorac A, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol, 2017, 13(4): 241-257.
|
10. |
van de Wetering J, Westendorp RG, van der Hoeven JG, et al. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol, 1996, 7(1): 145-150.
|
11. |
Martin PY, Chevrolet JC, Suter P, et al. Anticoagulation in patients treated by continuous venovenous hemofiltration: a retrospective study. Am J Kidney Dis, 1994, 24(5): 806-812.
|
12. |
赵宇亮, 张凌, 付平. 枸橼酸抗凝在肾脏替代治疗中的新进展. 中华内科杂志, 2012, 51(7): 571-573.
|
- 1. 付平, 张凌. 杂合肾脏替代治疗的临床应用. 中国血液净化, 2011, 10(1): 7-9.
- 2. Zhang L, Yang J, Eastwood GM, et al. Extended daily dialysis versus continuous renal replacement therapy for acute kidney injury: a meta-analysis. Am J Kidney Dis, 2015, 66(2): 322-330.
- 3. 王婷立, 张凌, 陈志文, 等. 枸橼酸抗凝在持续缓慢低效血液透析中的应用. 中华内科杂志, 2014, 53(12): 953-956.
- 4. 张凌, 王婷立, 赵宇亮, 等. 枸橼酸抗凝在持续缓慢低效血液透析中的疗效及安全性. 中华内科杂志, 2013, 52(6): 459-463.
- 5. Zhang L, Liao Y, Xiang J, et al. Simplified regional citrate anticoagulation using a calcium-containing replacement solution for continuous venovenous hemofiltration. J Artif Organs, 2013, 16(2): 185-192.
- 6. Mishra SB, Azim A, Prasad N, et al. A pilot randomized controlled trial of comparison between extended daily hemodialysis and continuous veno-venous hemodialysis in patients of acute kidney injury with septic shock. Indian J Crit Care Med, 2017, 21(5): 262-267.
- 7. Kitchlu A, Adhikari N, Burns KE, et al. Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study. BMC Nephrol, 2015, 16: 127.
- 8. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract, 2012, 120(4): C179-C184.
- 9. Chawla LS, Bellomo R, Bihorac A, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol, 2017, 13(4): 241-257.
- 10. van de Wetering J, Westendorp RG, van der Hoeven JG, et al. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol, 1996, 7(1): 145-150.
- 11. Martin PY, Chevrolet JC, Suter P, et al. Anticoagulation in patients treated by continuous venovenous hemofiltration: a retrospective study. Am J Kidney Dis, 1994, 24(5): 806-812.
- 12. 赵宇亮, 张凌, 付平. 枸橼酸抗凝在肾脏替代治疗中的新进展. 中华内科杂志, 2012, 51(7): 571-573.